Diagnostic Tests

Test Catalogue

10 tests shown

Category

Cardiovascular Panels

2 tests

Angiogenesis Panel (12-Plex)

Use this test to assess abnormalities of angiogenesis in cancer, autoimmune diseases, cardiovascular disease, or other chronic inflammatory conditions.

Analytes / Biomarkers
Angiopoietin-2, BMP-9, Endoglin, Endothelin-1, FGF-1, Follistatin, HB-EGF, HGF, Leptin, PLGF, VEGF-C, VEGF-D
Turnaround

1-5 days

Acceptable Sample Types

Plasma-EDTA

SAA/Cardiovascular Disease Panel (6-Plex)

Use this test to investigate the underlying molecular basis of suspected coagulopathies, cardiovascular disease, and acute or chronic inflammation

Analytes / Biomarkers
ADAMTS13, D-Dimer, SAA, sICAM-1, sP-Selectin, sVCAM-1
Turnaround

1-5 days

Acceptable Sample Types

Plasma-EDTA

Category

Complement Profile Panel

1 test

Complement Profile Panel (15-Plex)

Use this test to assess complement activation, deficiency, or dysregulation.

Analytes / Biomarkers
C1q, C2, C3, C3b/iC3b, C4, C4b, C5, C5a, C9, Factor B, Factor D, Factor H, Factor I, Mannose-Binding Lectin (MBL), Properdin
Turnaround

1-5 days

Acceptable Sample Types

Plasma-EDTA

Category

Cytokine, Chemokine & Growth Factor Panels

4 tests

Circulating Immune Checkpoint Panel (17-Plex)

Use this panel to investigate T cell activation and exhaustion, and to provide supportive information for assessing the potential suitability of checkpoint inhibitor therapies in cancer and autoimmune conditions.

Analytes / Biomarkers
BTLA, CD27, CD28, CD40, CD80/B7-1, CD86/B7-2, CTLA-4, GITR, GITRL, HVEM, ICOS, LAG-3, PD-1, PD-L1, PD-L2, TIM-3, TLR-2
Turnaround

1-5 Days

Acceptable Sample Types

Plasma-EDTA

Cytokine, Chemokine, and Growth Factor Panel (95-Plex)

Use this test to identify relevant therapy targets or investigate mechanisms of disease for autoimmune disorders (e.g., RA, SLE), autoinflammatory diseases (e.g., FMF, CAPS, sJIA), chronic inflammatory diseases (e.g., IBD, psoriatic arthritis, ankylosing spondylitis, Kawasaki disease), cytokine storm syndromes (e.g., MAS, HLH, post-HSCT or CAR-T hyperinflammation), neoplastic and paraneoplastic conditions (e.g., hematologic malignancies, paraneoplastic syndromes, cancer-associated inflammation), and complex chronic conditions (e.g., fibromyalgia, ME/CFS, long COVID, post-treatment Lyme disease syndrome).

Analytes / Biomarkers
6Ckine (CCL21), APRIL, BAFF, BCA-1 (CXCL13), CCL28, CTACK (CCL27), EGF, ENA-78 (CXCL5), Eotaxin (CCL11), Eotaxin-2 (CCL24), Eotaxin-3 (CCL26), FGF-2, Flt-3 Ligand, Fractalkine (CX3...
6Ckine (CCL21), APRIL, BAFF, BCA-1 (CXCL13), CCL28, CTACK (CCL27), EGF, ENA-78 (CXCL5), Eotaxin (CCL11), Eotaxin-2 (CCL24), Eotaxin-3 (CCL26), FGF-2, Flt-3 Ligand, Fractalkine (CX3CL1), G-CSF, GCP-2 (CXCL6), GM-CSF, Granzyme A, Granzyme B, GROα (CXCL1), HMGB1, I-309 (CCL1), IFNα2, IFNβ, IFNγ, IFNω, IL-1α, IL-1β, IL-1RA, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8 (CXCL8), IL-9, IL-10, IL-11, IL-12p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17E/IL-25, IL-17F, IL-18, IL-20, IL-21, IL-22, IL-23, IL-24, IL-27, IL-28A (IFNλ2), IL-29 (IFNλ1), IL-31, IL-33, IL-34, IL-35, IP-10 (CXCL10), I-TAC (CXCL11), LIF, Lymphotactin (XCL1), MCP-1 (CCL2), MCP-2 (CCL8), MCP-3 (CCL7), MCP-4 (CCL13), M-CSF, MDC (CCL22), MIG (CXCL9), MIP-1α (CCL3), MIP-1β (CCL4), MIP-1δ (CCL15), MIP-3α (CCL20), MIP-3β (CCL19), MPIF-1 (CCL23), PDGF-AA, PDGF-AB/BB, Perforin, RANTES (CCL5), sCD40L, sCD137, SCF, SDF-1 (CXCL12), sFas, sFasL, TARC (CCL17), TGFα, TNFα, TNFβ (LTα), TPO, TRAIL, TSLP, VEGF-A
Turnaround

1-5 Days

Acceptable Sample Types

Plasma, Serum, CSF

Focused Cytokine, Chemokine and Growth Factor Panel (15-Plex)

Use this test when identifying relevant therapy targets in severe or chronic inflammation.

Analytes / Biomarkers
GM-CSF, IFNγ, IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-8 (CXCL8), IL-10, IL-12p40, IL-12p70, IL-13, MCP-1 (CCL2), TNFα
Turnaround

1-5 Days

Acceptable Sample Types

Plasma-EDTA, Serum, CSF

Interferon Panel (9-Plex)

Use this test to assess the interferon response in viral infections, autoinflammatory interferopathies, and autoimmune diseases

Analytes / Biomarkers
IFNα2, IFNβ, IFNγ, IFNλ1, IFNλ2, IFNω, I-TAC (CXCL11), IP-10 (CXCL10), MIG (CXCL9)
Turnaround

1-5 Days

Acceptable Sample Types

Plasma, Serum

Category

Long COVID Vascular Health Panel

1 test

Long COVID Vascular Health Panel (18-Plex)

Use this panel to investigate dysfunctions in vascular and endothelial integrity, coagulation, and inflammation. The panel consists of circulating factors that may suggest abnormalities in angiogenesis (a response to persistent vascular injury), coagulation, vascular function and inflammatory responses, which are thought to be key features of long COVID pathogenesis.

Analytes / Biomarkers
ADAMTS13, Angiopoietin-2, BMP-9, D-Dimer, Endoglin, Endothelin-1, FGF-1, Follistatin, HB-EGF, HGF, Leptin, PLGF, SAA, sICAM-1, sP-Selectin, sVCAM-1, VEGF-C, VEGF-D
Turnaround

1-5 Days

Acceptable Sample Types

Plasma-EDTA

Category

Serum Amyloid A / ADAMTS13

1 test

Serum Amyloid A (SAA) / ADAMTS13 Panel (2-Plex)

Use this test for acute phase inflammatory detection, chronic inflammatory diseases

Analytes / Biomarkers
SAA, ADAMTS13
Turnaround

1-5 Days

Acceptable Sample Types

Plasma-EDTA, Serum (Reference intervals estimated from plasma-EDTA only - ADAMTS13 levels are higher in serum, so qualitative calls for that analyte may be misleading for serum samples)

Category

Soluble Cytokine Receptor Panel

1 test

Soluble Immune Receptor Panel (15-Plex)

Use this test to identify relevant therapy targets or investigate mechanisms of disease for inflammatory, autoimmune or neoplastic conditions.

Analytes / Biomarkers
sCD30, sCD163, sEGFR, sgp130, sIL-1RI, sIL-1RII, sIL-2Rα, sIL-4R, sIL-6R, sRAGE, sTNFRI, sTNFRII, sVEGFR1, sVEGFR2, sVEGFR3
Turnaround

1-5 Days

Acceptable Sample Types

Plasma-EDTA, Serum, CSF (sCD163 only available for plasma-EDTA).

Top